XML 58 R8.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net loss $ (4,104) $ (38,694)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Stock-based compensation 19,906 716
Non-cash gain on IPO transactions (5,476)
Note issuance for legal settlement 750
Provision for credit losses 18 (42)
Non-cash interest 1,112 1,422
Non-cash charge for Libertas warrants 1,152
Non-cash investor note interest 6,731
Change in investor notes at fair value 186 353
Non-cash (gain) loss on debt extinguishment (15,559) 10,461
Depreciation and amortization 12,009 12,640
Amortization of right-of-use lease assets 581 352
Change in fair value of contingent consideration (20,272) (2,400)
Change in fair value of warranty liability (1,843)  
Change in deferred taxes 279 (654)
Goodwill impairment 37,994
Changes in operating assets and liabilities:    
Accounts receivable (2,301) (7,908)
Related party receivables 398 (346)
Prepaid expenses and other assets (3,672) (1,524)
Inventory (1,712) (6,363)
Accounts payable, accrued expenses and other long-term liabilities (19,200) 12,796
Related party payables 6,691 1,226
Lease liabilities (552) (359)
Deferred revenue (6,916) (76)
Deferred compensation (638) 1,891
Net cash (used in) provided by operating activities (32,432) 21,485
Cash flows from investing activities:    
Purchase of property and equipment and investment in intangible assets (3,074) (789)
Net cash used in investing activities (3,074) (789)
Cash flows from financing activities:    
Proceeds from sale of common stock, net 140,908
Repurchase of common stock (19,413)
Change in lines of credit (127) (621)
Proceeds from borrowings 8,500 6,950
Repayments on borrowings (25,355) (1,542)
Proceeds from related party borrowings 231 1,374
Repayments on related party borrowings (5,150) (50)
Debt issuance costs paid (170) (475)
Proceeds from the exercise of warrants 3
Taxes paid related to net share settlements of common stock (1,233)
Payment of contingent consideration (8,535)
Cash paid to seller (3,246) (16,219)
Net cash provided by (used in) financing activities 86,413 (10,583)
Effect of exchange rate changes 2,733 (2,304)
Net increase in cash and restricted cash 53,640 7,809
Cash and restricted cash as of beginning of period 20,911 13,102
Cash and restricted cash as of end of period 74,551 20,911
Supplemental disclosures of non-cash information:    
Deferred compensation settled in common stock 4,670
Reclass between accrued expenses and notes payable 622
Reclass between accrued expenses and contingent consideration 5,268
Financing of insurance premiums 1,176 268
Purchases of property and equipment included in accounts payable 305
Return of property and cancellation of corresponding accounts payable 2,594
Right-of-use assets obtained in exchange for operating lease liabilities 3,451 381
Initial recognition of warrant liability 2,885
Reclass of warrants to equity 1,042
Debt settled in common stock 8,935
Contingent consideration settled in common stock 13,976
Issuance of Underwriter Warrants 2,030
Conversion of accounts payable to debt 357
Extinguishment of the carrying value of principal and interest $ 1,405